HOME >> BIOLOGY >> NEWS
Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue

MicroRNAs (miRNAs), tiny pieces of genetic material that can serve as stop signs for gene expression and protein synthesis, are thought to be important in the development of cancer. Now, researchers at Jefferson Medical College and the Kimmel Cancer Center of Thomas Jefferson University in Philadelphia have developed a technique that allows them to find which miRNA genes are expressed and how in both cancerous and normal tissue.

Scientists, led by Carlo Croce, M.D., director of Jefferson's Kimmel Cancer Center and professor of microbiology and immunology at Jefferson Medical College, have developed a microarray chip onto which they were able to put all the known miRNA genes in both human and mouse. They found that each tissue they tested had its own characteristic pattern of miRNA gene expression.

The work might enable scientists to gain a better understanding of the roles of miRNAs in cancer and provide targets for future drug development. They reported their findings June 21, 2004 online in the Proceedings of the National Academy of Sciences.

Dr. Croce explains that miRNAs are thought to play important roles in regulating gene expression during development and cell differentiation. MiRNAs inhibit the function of their targets, typically messenger RNA, which is involved in gene expression. They either degrade the messenger RNA or block its translation. Cells in organisms from yeast to mammals make interfering RNA to shut off gene expression in development.

Dr. Croce and his colleagues had previously shown that deletions in miRNA genes were involved in B-cell chronic lymphocytic leukemia (CLL), the most common adult leukemia in the Western world. They also had reported that human miRNA genes are frequently located in "fragile" areas of the genome that are vulnerable to mutation. "We think the miRNA genes are in fact involved in many human cancers," he says.

"As a result, we have a number of markers that allow us to characterize spe
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
22-Jun-2004


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
4. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
5. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
6. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
7. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
8. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
9. Jefferson scientists use gene repair technique to change albino mice hairs to black
10. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... ... March 04, 2020 , ... VGXI, ... announced it has been nominated as a finalist in the category of Best ... comes as VGXI expedites manufacturing of a DNA vaccine against the novel coronavirus, ...
(Date:3/2/2020)... (PRWEB) , ... March 02, 2020 , ... Toronto-based clinical ... is soon opening its newest office location just 5 minutes south of Clarksburg on ... orchard on the property, called End of the Rainbow Orchard, and decided it would ...
(Date:2/28/2020)... (PRWEB) , ... February 28, 2020 , ... Meridian ... 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian ... finalist for the Best Clinical Trial Network award. These nominations were the result of ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... ... March 10, 2020 , ... Ortho Clinical Diagnostics, a global leader ... announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen in a gel testing ... run on ORTHO VISION® and ORTHO VISION® Max in the United States and Canada. ...
(Date:3/3/2020)... Ill. (PRWEB) , ... March 03, 2020 , ... ... company serving the pharmaceutical, biotech and medical device industries, was recognized by INC. ... 5,000 puts forward annual lists to note industry leaders greatly impacting their spheres ...
(Date:2/21/2020)... (PRWEB) , ... February 20, 2020 , ... In a ... join guest speakers from Synteract including Lisa Dilworth, BS, MS, Vice President ... about these challenges, with feasible strategies and solutions to support patients, sites and sponsors. ...
(Date:2/19/2020)... , ... February 18, 2020 , ... ... for characterizing microbiome populations down to the strain level, recently unveiled a novel ... designed for efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA ...
Breaking Biology Technology:
Cached News: